More than 90% of STICs have p53 signatures and share identical TP53 mutations with invasive ovarian or peritoneal cancers suggesting that STICs are the site of origin for high grade serous carcinomas [8]. The gene discussed is TP53; the disease is serous adenocarcinoma.